title: A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines.
authors.forename: Shawn C
authors.initials: SC
authors.lastname: Kelly
authors.forename: Rhyannon
authors.initials: R
authors.lastname: Gonzalo
authors.forename: Marian
authors.initials: M
authors.lastname: Petrasko
mesh_terms: D000367:Age Factors; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood*; D048909:Diabetes Complications; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D044469:Racial Groups; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking; D012955:Societies, Medical
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol